OVID Ovid Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 13, 2026
$2.38
· % 处于52周区间
· 高于低点
· 至高点
$1.1852周低点
$3.1152周高点
市值 (MRQ)
$440M
P/E
-7.5
EPS
$-0.74
收入
$7M
OVID 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$2.38
市值 (MRQ)
$440M
P/E
-7.5
EPS
$-0.74
收入
$7M
ROE
-18.7%
52周区间
$1–$3
OVID 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$7M2020-12-31 → 2025-12-31
EPS$-0.742020-12-31 → 2023-12-31
自由现金流$-38M2017-12-31 → 2025-12-31
净利率-2178.9%2020-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | OVID | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -7.55年均值 ≈-2.2 | ≈-2.2 | · | · | |
| P/S (TTM) | 277.85年均值 ≈174.6 | ≈174.6 | 3.7 | 估值过高 | |
| 市净率 (MRQ) | 2.15年均值 ≈1.6 | ≈1.6 | 3.0 | 低估 | |
| Price / FCF (股价/自由现金流) | -10.45年均值 ≈-2.7 | ≈-2.7 | · | · | |
| Price / Cash Flow (市现率) | -10.45年均值 ≈-2.7 | ≈-2.7 | · | · | |
| 市净率（有形资产） (MRQ) | 2.15年均值 ≈1.5 | ≈1.5 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | OVID | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -3686.7%5年均值 ≈-4839.2% | ≈-4839.2% | -47.4% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | -3681.4%5年均值 ≈-4793.4% | ≈-4793.4% | -47.4% | 弱 | |
| 税前利润率 (TTM) | -2178.9%5年均值 ≈-4286.8% | ≈-4286.8% | -61.1% | 弱 | |
| 净利润率 (TTM) | -2178.9%5年均值 ≈-4287.0% | ≈-4287.0% | -28.8% | 弱 | |
| ROA | -14.3%5年均值 ≈2.6% | ≈2.6% | -14.3% | 持平 | |
| ROE | -18.7%5年均值 ≈-12.1% | ≈-12.1% | -14.4% | 弱 | |
| ROIC | -32.5%5年均值 ≈-18.4% | ≈-18.4% | -12.1% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | OVID | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 12.45年均值 ≈12.5 | ≈12.5 | 10.4 | 流动性强 | |
| Quick Ratio (速动比率) | 1.65年均值 ≈5.8 | ≈5.8 | 2.9 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | OVID | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 1181.3%5年均值 ≈520.8% | ≈520.8% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 69.0%5年均值 ≈-28.5% | ≈-28.5% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -10.5% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | OVID | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.15年均值 ≈0.4 | ≈0.4 | 0.4 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$315.3K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
37.4%
下次报告
十一月 10, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 18, 2026 | $-0.08 | $-0.12 | 35.2% |
| 2026年3月31日 | 五月 13, 2026 | $-0.12 | $-0.12 | 2.2% |
| 2025年12月31日 | $0.06 | $-0.12 | 149.4% | |
| 2025年9月30日 | $-0.17 | $-0.15 | -11.2% | |
| 2025年6月30日 | $-0.06 | $-0.16 | 63.6% | |
| 2025年3月31日 | $-0.14 | $-0.14 | -0.43% | |
| 2024年12月31日 | $-0.13 | $-0.17 | 23.2% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $7M | $566.0K | $392.0K | $2M | $208M | $13M | |
| R&D Expense | $26M | $37M | $29M | $25M | $47M | $63M | |
| SG&A Expense | $24M | $26M | $31M | $32M | $37M | $31M | |
| Operating Expenses | $50M | $62M | $60M | $57M | $84M | $94M | |
| Operating Income | $-42M | $-62M | $-59M | $-56M | $124M | $-81M | |
| Interest Income | $2M | $4M | $5M | · | · | · | |
| Other Non-op | $25M | $35M | $7M | $1M | $-45.7K | · | |
| Pretax Income | $-17M | $-26M | $-52M | $-54M | $124M | $-81M | |
| Income Tax | $0 | $0 | $0 | $0 | $1M | $0 | |
| Net Income | $-17M | $-26M | $-52M | $-54M | $123M | $-81M | |
| EPS (Basic) | · | · | $-0.74 | $-0.77 | $1.78 | $-1.39 | |
| EPS (Diluted) | · | · | $-0.74 | $-0.77 | $1.76 | $-1.39 | |
| Shares (Basic) | · | · | 70,580,604 | 70,424,819 | 67,479,403 | 58,451,293 | |
| Shares (Diluted) | · | · | 70,580,604 | 70,424,819 | 68,067,992 | 58,451,293 | |
| EBITDA | $-42M | · | $-59M | $-55M | $124M | $-81M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $26M | $27M | $45M | $188M | $72M | |
| Prepaid Expense | $5M | $3M | $4M | $2M | $3M | $3M | |
| Current Assets | $74M | $56M | $110M | $131M | $190M | $75M | |
| PP&E (Net) | $252.0K | $433.0K | $769.0K | $1M | $242.8K | $135.6K | |
| Accum. Depreciation | $2M | $1M | $1M | $581.4K | $262.2K | $185.3K | |
| Intangibles | $0 | $100.0K | $200.0K | $222.1K | $164.1K | $319.0K | |
| Other Non-current Assets | $0 | $92.0K | $210.0K | $261.2K | $260.1K | $318.9K | |
| Total Assets | $151M | $92M | $144M | $155M | $195M | $76M | |
| Accounts Payable | $2M | $3M | $4M | $2M | $7M | $5M | |
| Accrued Liabilities | $5M | $6M | $7M | $5M | $8M | $12M | |
| Current Liabilities | $8M | $11M | $11M | $7M | $15M | $22M | |
| Capital Leases | $12M | $13M | $15M | $16M | $0 | · | |
| Total Liabilities | $20M | $24M | $56M | $23M | $15M | $32M | |
| Common Stock | $130.0K | $71.0K | $71.0K | $70.5K | $70.4K | $65.7K | |
| Paid-in Capital | $452M | $372M | $366M | $358M | $351M | · | |
| Retained Earnings | $-322M | $-304M | $-278M | $-226M | $-171M | $-294M | |
| AOCI | $-202.0K | $-35.0K | $1.0K | $-42.2K | $0 | · | |
| Stockholders' Equity | $131M | $68M | $88M | $132M | $180M | $44M | |
| Liabilities + Equity | $151M | $92M | $144M | $155M | $195M | $76M | |
| Shares Outstanding | 130,184,353 | 71,009,866 | 70,691,992 | 70,466,885 | 70,364,912 | 65,743,170 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $273.0K | $613.0K | $568.0K | $512.5K | $237.1K | $306.8K | |
| Stock-based Comp | $5M | $6M | $7M | $7M | $5M | $8M | |
| Deferred Tax | · | · | · | · | · | $6M | |
| Amort. of Intangibles | $100.0K | $200.0K | $100.0K | $193.3K | $160.2K | $247.0K | |
| Other Non-cash | $-26M | · | $-1M | $-8M | $-10M | $16M | |
| Operating Cash Flow | $-38M | $-56M | $-46M | $-55M | $119M | $-52M | |
| CapEx | $0 | $71.0K | $40.0K | $1M | $184.0K | $127.2K | |
| Investing Cash Flow | $-50M | $55M | $-3M | $-88M | $-2M | $35M | |
| Stock Issued | · | · | · | · | $0 | $47M | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $75M | $622.0K | $31M | $180.7K | $904.1K | $47M | |
| Net Change in Cash | $-13M | $-740.0K | · | $-143M | $118M | $30M | |
| Free Cash Flow | $-38M | · | $-46M | $-56M | $118M | $-52M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -585.2% | · | -15134.6% | -3696.4% | 59.6% | -645.4% | |
| Net Margin | -240.1% | · | -13362.2% | -3604.7% | 59.0% | -642.3% | |
| Pretax Margin | -240.1% | · | -13362.2% | -3604.7% | 59.6% | · | |
| EBITDA Margin | -581.4% | · | -14989.5% | -3662.3% | 59.7% | -643.0% | |
| ROA | -14.3% | · | -35.0% | -31.0% | 90.8% | -103.4% | |
| ROE | -18.7% | · | -55.4% | -39.5% | 65.2% | -151.1% | |
| ROIC | -32.5% | · | -67.5% | -42.0% | 68.4% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | · | 9.6 | 18.8 | 12.9 | 3.4 | |
| Quick Ratio | 1.6 | · | 2.4 | 6.4 | 12.7 | 3.3 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 1.5 | 0.2 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.00 | · | $1.24 | $1.88 | $2.55 | $0.66 | |
| Revenue / Share | · | · | $0.01 | $0.02 | $3.06 | · | |
| Cash Flow / Share | · | · | $-0.65 | $-0.78 | $1.74 | · | |
| Cash / Share | $0.10 | · | $0.38 | $0.64 | $2.67 | $1.10 | |
| EPS (TTM) | $-0.41 | $-0.41 | $-0.74 | $-0.77 | $1.76 | $-1.39 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 1181.3% | 44.4% | -73.9% | -99.3% | 1551.6% | · | |
| Revenue CAGR 3Y | 69.0% | -86.1% | -68.6% | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $566.0K | $392.0K | $2M | $208M | $13M | |
| Net Income TTM | $-17M | $-26M | $-52M | $-54M | $123M | $-81M | |
| Market Cap | $212M | · | $228M | $131M | $226M | $152M | |
| P/E | -4.0 | -2.3 | -4.4 | -2.4 | 1.8 | -1.7 | |
| P/S | 29.3 | · | 580.7 | 87.2 | 1.1 | 12.0 | |
| P/B | 1.6 | · | 2.6 | 1.0 | 1.3 | 3.5 | |
| P / Tangible Book | 1.6 | 1.0 | 2.6 | 1.0 | 1.3 | 3.5 | |
| P / Cash Flow | -5.5 | · | -5.0 | -2.4 | 1.9 | -2.9 | |
| P / FCF | -5.5 | · | -5.0 | -2.3 | 1.9 | -2.9 | |
| Earnings Yield | -25.1% | -43.9% | -23.0% | -41.4% | 54.8% | -60.2% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $733.0K | $0 | $718.0K | $132.0K | $6M | $130.0K | $76.0K | $173.0K | $169.0K | $148.0K | $142.0K | $109.0K | $75.0K | $66.0K | $46.3K | $11.1K | |
| R&D Expense | $10M | $11M | $7M | $6M | $6M | $7M | $6M | $8M | $13M | $10M | $11M | $5M | $6M | $7M | $6M | $5M | |
| SG&A Expense | $6M | $7M | $6M | $7M | $5M | $6M | $5M | $6M | $8M | $7M | $8M | $7M | $8M | $8M | $7M | $8M | |
| Operating Expenses | $16M | $18M | $13M | $13M | $11M | $13M | $11M | $13M | $21M | $18M | $18M | $12M | $14M | $15M | $12M | $13M | |
| Operating Income | $-16M | $-18M | $-12M | $-13M | $-5M | $-13M | $-11M | $-13M | $-21M | $-17M | $-18M | $-12M | $-14M | $-15M | $-12M | $-13M | |
| Interest Income | $2M | $737.0K | $848.0K | $303.0K | $384.0K | $491.0K | $650.0K | $947.0K | $991.0K | $1M | · | · | · | · | · | · | |
| Other Non-op | $689.0K | $858.0K | $22M | $365.0K | $389.0K | $2M | $1M | $-780.0K | $29M | $6M | $3M | $776.0K | $2M | $2M | $618.1K | $836.1K | |
| Pretax Income | $-15M | $-17M | $10M | $-12M | $-5M | $-10M | $-9M | $-14M | $9M | $-12M | $-15M | $-11M | $-12M | $-13M | $-12M | $-12M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-50.0K | $0 | |
| Net Income | $-15M | $-17M | $10M | $-12M | $-5M | $-10M | $-9M | $-14M | $9M | $-12M | $-15M | $-11M | $-12M | $-13M | $-12M | $-12M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-0.20 | $0.12 | $-0.17 | · | $-0.16 | $-0.18 | $-0.19 | $-0.16 | $-0.17 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-0.20 | $0.12 | $-0.17 | · | $-0.16 | $-0.18 | $-0.19 | $-0.16 | $-0.17 | |
| Shares (Basic) | · | · | · | · | · | · | · | 70,975,778 | 70,916,471 | 70,716,929 | · | 70,618,609 | 70,534,181 | 70,490,704 | · | 70,430,554 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 70,975,778 | 71,200,798 | 70,716,929 | · | 70,618,609 | 70,534,181 | 70,490,704 | · | 70,430,554 | |
| EBITDA | $-16M | $-18M | · | $-13M | $-5M | $-12M | · | $-13M | $-21M | $-17M | · | $-12M | $-14M | $-15M | · | $-13M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $94M | $13M | $21M | $28M | $21M | $26M | $15M | $30M | $31M | $27M | $57M | $72M | $63M | $45M | $58M | |
| Prepaid Expense | $6M | $5M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $3M | $4M | $5M | $6M | $2M | $2M | $3M | |
| Current Assets | $124M | $160M | $74M | $29M | $42M | $46M | $56M | $66M | $81M | $93M | $110M | $92M | $102M | $120M | $131M | $140M | |
| PP&E (Net) | $201.0K | $217.0K | $252.0K | $269.0K | $285.0K | $346.0K | $433.0K | $509.0K | $618.0K | $686.0K | $769.0K | $856.5K | $955.6K | $1M | $1M | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $899.5K | $795.1K | $689.8K | $581.4K | $449.8K | |
| Intangibles | $0 | $0 | $0 | $0 | $0 | $38.0K | $100.0K | $155.0K | $219.0K | $148.0K | $200.0K | $222.1K | $263.4K | $185.9K | $222.1K | $275.4K | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $39.0K | $92.0K | $182.0K | $246.0K | $174.0K | $210.0K | $248.7K | $290.0K | $212.5K | $261.2K | $275.4K | |
| Total Assets | $232M | $226M | $151M | $64M | $77M | $82M | $92M | $103M | $118M | $132M | $144M | $125M | $136M | $143M | $155M | $165M | |
| Accounts Payable | $4M | $9M | $2M | $2M | $4M | $2M | $3M | $3M | $5M | $4M | $4M | $1M | $4M | $2M | $2M | $1M | |
| Accrued Liabilities | $4M | $5M | $5M | $3M | $3M | $6M | $6M | $8M | $8M | $4M | $7M | $6M | $5M | $4M | $5M | $6M | |
| Current Liabilities | $10M | $16M | $8M | $7M | $9M | $9M | $11M | $12M | $14M | $9M | $11M | $9M | $10M | $7M | $7M | · | |
| Capital Leases | $11M | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $16M | |
| Total Liabilities | $22M | $27M | $20M | $19M | $22M | $22M | $24M | $26M | $29M | $53M | $56M | $24M | $26M | $22M | $23M | $23M | |
| Common Stock | $185.0K | $167.0K | $130.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $70.7K | $70.6K | $70.5K | $70.5K | $70.5K | |
| Paid-in Capital | $564M | $537M | $452M | $376M | $375M | $374M | $372M | $371M | $370M | $368M | $366M | $364M | $362M | $360M | $358M | · | |
| Retained Earnings | $-354M | $-339M | $-322M | $-331M | $-319M | $-315M | $-304M | $-295M | $-281M | $-290M | $-278M | $-263M | $-251M | $-239M | $-226M | $-214M | |
| AOCI | $-750.0K | $-422.0K | $-202.0K | $-126.0K | $-69.0K | $-47.0K | $-35.0K | $36.0K | $-12.0K | $-19.0K | $1.0K | $-3.9K | $5.2K | $5.6K | $-42.2K | $-82.8K | |
| Stockholders' Equity | $210M | $198M | $131M | $45M | $56M | $59M | $68M | $76M | $89M | $78M | $88M | $101M | $111M | $121M | $132M | $142M | |
| Liabilities + Equity | $232M | $226M | $151M | $64M | $77M | $82M | $92M | $103M | $118M | $132M | $144M | $125M | $136M | $143M | $155M | $165M | |
| Shares Outstanding | 184,755,735 | 167,266,466 | 130,184,353 | 71,151,981 | 71,109,514 | 71,109,514 | 71,009,866 | 71,009,866 | 70,971,577 | 70,783,961 | 70,691,992 | 70,680,551 | 70,602,793 | 70,491,510 | 70,466,885 | 70,466,885 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16.0K | $35.0K | $17.0K | $16.0K | $99.0K | $141.0K | $160.0K | $169.0K | $148.0K | $136.0K | $140.0K | $145.9K | $137.3K | $145.0K | $185.0K | $155.4K | |
| Stock-based Comp | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Amort. of Intangibles | $0 | $0 | $9.0K | $0 | $38.0K | $53.0K | $56.0K | $64.0K | $45.0K | $35.0K | $-9.0K | $41.0K | $32.0K | $36.0K | $75.8K | $53.3K | |
| Other Non-cash | · | $2M | · | · | · | $-1M | · | · | · | $-7M | · | · | · | $-817.2K | · | · | |
| Operating Cash Flow | $-18M | $-14M | $-10M | $-13M | $-5M | $-10M | $-10M | $-15M | $-14M | $-17M | $-12M | $-10M | $-12M | $-12M | $-9M | $-13M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $22.0K | $-4.0K | $34.0K | $19.0K | $13.0K | $5.6K | $7.4K | $14.0K | $119.9K | $18.6K | |
| Investing Cash Flow | $-87M | $6M | $-72M | $5M | $12M | $5M | $21M | $292.0K | $13M | $20M | $-49M | $-4M | $20M | $30M | $-4M | $-2M | |
| Stock Issued | $1.0K | $2M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $22M | $89M | $75M | $15.0K | $0 | $13.0K | $0 | $38.0K | $356.0K | $228.0K | $30M | $223.9K | $211.0K | $67.0K | $-43.6K | $81.6K | |
| Net Change in Cash | $-83M | $81M | · | · | $7M | $-5M | · | · | · | · | · | · | · | · | · | $-15M | |
| Free Cash Flow | · | · | · | · | · | $-10M | · | · | · | $-17M | · | · | · | $-12M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2141.6% | · | · | -9487.1% | -80.9% | -9653.9% | · | -7645.1% | -12140.2% | -11768.2% | · | -11038.5% | -18896.0% | -22509.5% | · | -115329.3% | |
| Net Margin | -2047.6% | · | · | -9210.6% | -74.7% | -7873.1% | · | -8096.0% | 5042.0% | -7901.3% | · | -10325.9% | -16544.4% | -20187.7% | · | -107798.3% | |
| Pretax Margin | -2047.6% | · | · | -9210.6% | -74.7% | -7873.1% | · | -8096.0% | 5042.0% | -7901.3% | · | -10325.9% | -16544.4% | -20187.7% | · | -107798.3% | |
| EBITDA Margin | -2141.6% | · | · | -9487.1% | -80.9% | -9545.4% | · | -7645.1% | -12140.2% | -11676.3% | · | -11038.5% | -18896.0% | -22290.9% | · | -115329.3% | |
| ROA | -9.7% | -11.1% | · | -14.6% | -4.8% | -9.6% | · | -12.3% | 6.7% | -8.5% | · | -7.8% | -7.9% | -8.0% | · | -6.4% | |
| ROE | -11.3% | -13.2% | · | -20.1% | -6.5% | -14.9% | · | -15.8% | 8.5% | -11.7% | · | -9.2% | -9.4% | -9.3% | · | -7.1% | |
| ROIC | -7.5% | -9.0% | · | -28.0% | -9.1% | -21.2% | · | -17.3% | -23.1% | -22.2% | · | -11.9% | -12.8% | -12.3% | · | -9.0% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.4 | 10.2 | · | 4.2 | 4.7 | 4.9 | · | 5.7 | 5.7 | 10.5 | · | 10.6 | 10.1 | 17.8 | · | · | |
| Quick Ratio | 1.1 | 6.0 | · | 3.0 | 3.2 | 2.3 | · | 1.3 | 2.1 | 3.5 | · | 6.6 | 7.1 | 9.4 | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.14 | $1.19 | · | $0.63 | $0.78 | $0.83 | · | $1.07 | $1.25 | $1.11 | · | $1.43 | $1.57 | $1.72 | · | $2.02 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.24 | · | · | · | $-0.17 | · | · | |
| Cash / Share | $0.06 | $0.56 | · | $0.29 | $0.40 | $0.30 | · | $0.21 | $0.42 | $0.43 | · | $0.81 | $1.01 | $0.89 | · | $0.83 | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | $-0.69 | $-0.70 | $-0.73 | · | $-0.98 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $7M | · | $7M | $7M | $548.0K | · | $632.0K | $568.0K | $474.0K | · | $296.3K | $198.4K | $123.4K | · | $1M | |
| Net Income TTM | $-34M | $-24M | · | $-36M | $-38M | $-25M | · | $-33M | $-30M | $-51M | · | $-49M | $-49M | $-51M | · | $-69M | |
| Market Cap | $497M | $371M | · | $92M | $23M | $22M | · | $84M | $55M | $216M | · | $271M | $232M | $182M | · | $130M | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | -5.6 | -4.7 | -3.5 | · | -1.9 | |
| P/S | 314.0 | 52.1 | · | 14.0 | 3.5 | 40.5 | · | 132.6 | 96.1 | 455.5 | · | 916.1 | 1167.3 | 1474.0 | · | 89.0 | |
| P/B | 2.4 | 1.9 | · | 2.1 | 0.4 | 0.4 | · | 1.1 | 0.6 | 2.8 | · | 2.7 | 2.1 | 1.5 | · | 0.9 | |
| P / Tangible Book | 2.4 | 1.9 | · | 2.1 | 0.4 | 0.4 | · | 1.1 | 0.6 | 2.8 | · | 2.7 | 2.1 | 1.5 | · | 0.9 | |
| P / Cash Flow | · | -26.7 | · | · | · | -2.2 | · | · | · | -12.9 | · | · | · | -15.0 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | -18.0% | -21.3% | -28.3% | · | -53.3% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $7M | $566.0K | $392.0K | $2M | $208M |
| 营业利润率 % | -585.2% | · | -15134.6% | -3696.4% | 59.6% |
| 净收入 | $-17M | $-26M | $-52M | $-54M | $123M |
| 稀释后每股收益 (EPS) | · | · | $-0.74 | $-0.77 | $1.76 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 9.0 | · | 9.6 | 18.8 | 12.9 |
| 速动比率 | 1.6 | · | 2.4 | 6.4 | 12.7 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-38M | · | $-46M | $-56M | $118M |
机构持有人 (13F) 142 家申报者 · $378.9M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
142
持有价值
$378.9M
新仓位
46
已退出持仓
17
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 46 (+15 与上一季度对比) | 17 (+9 与上一季度对比) | 34 (-1 与上一季度对比) | 29 (+8 与上一季度对比) | +21.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | $31774928 | 11812241 | 8.39% | 股份 |
| BlackRock, Inc. | $29115162 | 10823480 | 7.68% | 股份 |
| RA CAPITAL MANAGEMENT, L.P. | $28247604 | 10500968 | 7.45% | 股份 |
| Affinity Asset Advisors, LLC | $27288872 | 10144562 | 7.20% | 股份 |
| JANUS HENDERSON GROUP PLC | $23731510 | 10714000 | 6.26% | 股份 |
| STATE STREET CORP | $21253058 | 7900765 | 5.61% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $20874707 | 7760114 | 5.51% | 股份 |
| ADAR1 Capital Management, LLC | $19953019 | 7417479 | 5.27% | 股份 |
| Balyasny Asset Management L.P. | $18074314 | 6719076 | 4.77% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $16580571 | 6163781 | 4.38% | 股份 |
| FEDERATED HERMES, INC. | $16009982 | 5951666 | 4.23% | 股份 |
| BRAIDWELL LP | $15923358 | 5919464 | 4.20% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $10957549 | 4072653 | 2.89% | 股份 |
| TAKEDA PHARMACEUTICAL CO LTD | $9791595 | 7531996 | 2.58% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8342037 | 3101129 | 2.20% | 股份 |
| STEMPOINT CAPITAL LP | $6502491 | 2417283 | 1.72% | 股份 |
| Ikarian Capital, LLC | $6105503 | 2269704 | 1.61% | 股份 |
| Point72 Asset Management, L.P. | $5234006 | 1945727 | 1.38% | 股份 |
| VANGUARD GROUP INC | $5007730 | 3072227 | 1.32% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $3639570 | 1353000 | 0.96% | 股份 |
| NORTHERN TRUST CORP | $3352114 | 1246139 | 0.88% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $3068626 | 1140753 | 0.81% | 股份 |
| Propel Bio Management, LLC | $3000797 | 1115538 | 0.79% | 股份 |
| Rosalind Advisors, Inc. | $2980504 | 1107994 | 0.79% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2773237 | 1030943 | 0.73% | 股份 |
| Sio Capital Management, LLC | $2704348 | 1005334 | 0.71% | 股份 |
| Ensign Peak Advisors, Inc | $2657946 | 988084 | 0.70% | 股份 |
| Nuveen, LLC | $2402853 | 893254 | 0.63% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $2239097 | 832378 | 0.59% | 股份 |
| WELLS FARGO & COMPANY/MN | $2222494 | 826206 | 0.59% | 股份 |
| ORBIMED ADVISORS LLC | $2009430 | 747000 | 0.53% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1984569 | 737758 | 0.52% | 股份 |
| Saturn V Capital Management LP | $1783631 | 663060 | 0.47% | 股份 |
| Ally Bridge Group (NY) LLC | $1680069 | 624561 | 0.44% | 股份 |
| UBS Group AG | $1234487 | 458917 | 0.33% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1194473 | 444042 | 0.32% | 股份 |
| Bank of New York Mellon Corp | $1119897 | 416318 | 0.30% | 股份 |
| BANK OF AMERICA CORP /DE/ | $1101528 | 409490 | 0.29% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $1043445 | 387767 | 0.28% | 股份 |
| GOLDMAN SACHS GROUP INC | $894942 | 332692 | 0.24% | 股份 |
| Informed Momentum Co LLC | $698407 | 259631 | 0.18% | 股份 |
| Atom Investors LP | $677439 | 251836 | 0.18% | 股份 |
| CIBC WORLD MARKET INC. | $588709 | 218851 | 0.16% | 股份 |
| Parkman Healthcare Partners LLC | $532477 | 197947 | 0.14% | 股份 |
| SEI INVESTMENTS CO | $529083 | 196685 | 0.14% | 股份 |
| CITIGROUP INC | $513946 | 191058 | 0.14% | 股份 |
| Invesco Ltd. | $470481 | 174900 | 0.12% | 股份 |
| RHUMBLINE ADVISERS | $457666 | 170139 | 0.12% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $455638 | 169382 | 0.12% | 股份 |
| DEUTSCHE BANK AG\ | $401862 | 149391 | 0.11% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Mark Feldberg, TLS Advisors LLC, Shira Capital LLC, TradeLink Securities LLC, Tripletail Capital Management LP ×5 申报 | 2020年5月27日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 20 位内幕人士 · 9 位高管 · 8 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Margaret A. Alexander | President and CEO | 2026年2月26日 A | 61750 | 0 | 1 | $-16901 |
| Charles Ross Carter | Chief Financial Officer | 2026年7月6日 A | 94375 | 0 | 0 | $0 |
| Yaron Werber | CBO, CFO, Sec. and Treas. | 2018年1月19日 A | · | 0 | 0 | $0 |
| Amit Rakhit | President and CMO | 2021年7月14日 M | 726823 | 0 | 0 | $0 |
| Jason Tardio | Chief Operating Officer | 2024年2月22日 A | 28125 | 0 | 0 | $0 |
| Thomas Michael Perone | General Counsel, Secretary | 2024年2月22日 A | 28125 | 0 | 0 | $0 |
| Dirk Haasner | SVP, Global Regulatory Affairs | 2020年12月17日 A | · | 0 | 0 | $0 |
| Timothy Daly | EVP,Finance & Corp. Controller | 2020年12月17日 A | · | 0 | 0 | $0 |
| Ana Ward | SVP and General Counsel | 2019年2月24日 A | · | 0 | 0 | $0 |
| Anna Greka | 董事 | 2026年6月15日 A | · | 0 | 0 | $0 |
| Kevin Joseph Fitzgerald | 董事 | 2026年4月7日 A | 17578 | 0 | 0 | $0 |
| Stelios Papadopoulos | 董事 | 2026年4月7日 A | 217578 | 0 | 0 | $0 |
| Karen Bernstein | 董事 | 2026年2月26日 A | 20000 | 0 | 0 | $0 |
| Robert Michael Poole | 董事 | 2024年2月22日 A | · | 0 | 0 | $0 |
| Douglas E Williams | 董事 | 2021年5月17日 A | 5000 | 0 | 0 | $0 |
| Matthew During | 董事 | 2019年4月1日 A | 4307314 | 0 | 0 | $0 |
| Bart Friedman | · | 2026年4月7日 A | 8789 | 0 | 0 | $0 |
| Jeremy M Levin | · | 2026年3月23日 M | 3735048 | 0 | 0 | $0 |
| Barbara Gayle Duncan | · | 2026年2月26日 A | · | 0 | 0 | $0 |
| Jeffrey A Rona | · | 2026年2月26日 A | 156313 | 0 | 1 | $-12384 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 17 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBRN · iShares Trust | 0.46% | 13036 SH | 2026年9月11日 | 每日 |
| IWC · iShares Trust | 0.09% | 516966 SH | 2026年9月11日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.08% | 167199 NS | 2026年7月31日 | N-PORT |
| PWS · Pacer Funds Trust | 0.02% | 2284 NS | 2026年7月31日 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 117475 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.01% | 3906782 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 137815 SH | 2026年10月2日 | 每日 |
| RSSL · Global X Funds | 0.01% | 72842 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1952040 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 881326 SH | 2026年8月19日 | 每日 |
| IWO · iShares Trust | 0.00% | 169022 SH | 2026年9月11日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.00% | 83973 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 342580 SH | 2026年9月11日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 5653216 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 19401 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 12741 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 1268401 SH | 2026年9月11日 | 每日 |
OVID 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 16 位分析师
买入
中位数目标
$5.00
+110.1%
7 43.8%
强烈买入
8 50.0%
买入
1 6.2%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
9 位分析师 · 2026-10-01平均目标 $5.92 +148.6%
← 低于所有目标
当前价格 $2.38
最低$4.00
平均值$5.92
最高$9.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 13, 2026 申报